Metraipolis › archive › dc_bbb2947134eb
Third-Generation Antipsychotics as Augmentation in Treatment-Resistant Obsessive-Compulsive Disorder: A Narrative Review of Efficacy and Tolerability — Europe PMC PMID:41595713
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41595713
- DOI
- 10.3390/biomedicines14010179
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T19:31:15.606Z
- SHA-256 of the archived text
30d37806b5acdd103d2567fec47b5f7e1525cc772298e69cfe4b422705fa4cd3- Stable URL of this page
https://metraipolis.com/documento/dc_bbb2947134eb
How to cite
Third-Generation Antipsychotics as Augmentation in Treatment-Resistant Obsessive-Compulsive Disorder: A Narrative Review of Efficacy and Tolerability — Europe PMC PMID:41595713 — Europe PMC (en), https://europepmc.org/article/MED/41595713 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bbb2947134eb (Metraipolis archive dc_bbb2947134eb, sha256 30d37806b5acdd103d2567fec47b5f7e1525cc772298e69cfe4b422705fa4cd3)
BibTeX
@misc{dcbbb2947134eb,
title = {Third-Generation Antipsychotics as Augmentation in Treatment-Resistant Obsessive-Compulsive Disorder: A Narrative Review of Efficacy and Tolerability — Europe PMC PMID:41595713},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41595713},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bbb2947134eb; sha256 30d37806b5acdd103d2567fec47b5f7e1525cc772298e69cfe4b422705fa4cd3},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41595713. Agents can read the archived copy with the MCP tool read_document.